WallStreetZenWallStreetZen

NASDAQ: MAZE
Maze Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Maze Therapeutics revenue was $167.50M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MAZE annual revenue was $167.5M, with Infinity% growth year-over-year.

MAZE revenue history

Current Revenue
$167.5M
Current Earnings
$3.4M
Current Profit Margin
2%

Be the first to know when MAZE announces revenue.

MAZE Revenue History By Year

MAZE Yearly RevenueMAZE RevenueMAZE ChangeMAZE Revenue Growth
2024-12-31$167.50MN/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Maze Therapeutics Revenue FAQ

What was MAZE's revenue last quarter?

Maze Therapeutics (NASDAQ: MAZE) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Maze Therapeutics's revenue was $0.00.

What was Maze Therapeutics's revenue in 2024?

Maze Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $167.50 million, a Infinity% increase year over year.

How much does Maze Therapeutics make in a day?

Based on Maze Therapeutics annual revenue for the past two years, MAZE makes an average of $229,452.05 per day.

What was Maze Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Maze Therapeutics's revenue has grown null year over year. Maze Therapeutics's revenue in the past year totaled $167.50 million.

How much does Maze Therapeutics make in a year?

Maze Therapeutics's revenue by year for the past two years is:
  • Maze Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $167.50 million, a Infinity% increase year over year.
  • Maze Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.